Log In
BCIQ
Print this Print this
 

Simplexa EBV test

  Manage Alerts
Collapse Summary General Information
Company Quest Diagnostics Inc.
Descriptionin vitro assay to detect EBV nucleic acids in whole blood specimens
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentApproved
Standard IndicationInfectious, Diagnostic
Indication DetailsDiagnose Epstein-Barr virus (EBV) infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$300.0M

$300.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/30/2016

$300.0M

$300.0M

0

Get a free BioCentury trial today